Xiaojing Yan

1.3k total citations
41 papers, 458 citations indexed

About

Xiaojing Yan is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Xiaojing Yan has authored 41 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 14 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Xiaojing Yan's work include Acute Myeloid Leukemia Research (13 papers), Multiple Myeloma Research and Treatments (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Xiaojing Yan is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Multiple Myeloma Research and Treatments (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Xiaojing Yan collaborates with scholars based in China, United States and Australia. Xiaojing Yan's co-authors include Chen Zhu, Sai‐Juan Chen, Xing Fan, Zhaohui Gu, Bing Chen, Jie Jin, Yanyan Wang, Yan Han, Yongmei Zhu and Haimin Chen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Biochemical and Biophysical Research Communications.

In The Last Decade

Xiaojing Yan

29 papers receiving 448 citations

Peers

Xiaojing Yan

HEMAT

GENET

Ashley Ringrose Canada

Monique Silvy France

J. M. Trujillo United States

Michele Vigolo Switzerland

Keiko Sugihara Japan

Anna Demurtas Italy

Thomas L. Cibull United States

Takeo Fujimoto Japan

Edouard Randriamalala France

K Sugita Japan

Ashley Ringrose Canada

Xiaojing Yan

182 ×0.7

HEMAT

90 ×0.4

82 ×0.8

GENET

6 ×0.1

33 ×0.6

Citations per year, relative to Xiaojing Yan Xiaojing Yan (= 1×) peers Ashley Ringrose

Countries citing papers authored by Xiaojing Yan

Since Specialization

Citations

This map shows the geographic impact of Xiaojing Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojing Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojing Yan more than expected).

Fields of papers citing papers by Xiaojing Yan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojing Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojing Yan. The network helps show where Xiaojing Yan may publish in the future.

Co-authorship network of co-authors of Xiaojing Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojing Yan. A scholar is included among the top collaborators of Xiaojing Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojing Yan. Xiaojing Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shi, Yuankai, Jianfang Sun, Mingzhi Zhang, et al.. (2025). Economic burden and health-related quality of life in Chinese patients with mycosis fungoides and Sézary syndrome. PubMed. 3(5). 434–440.

Zhang, Jingyi, Zhenwei Zhang, Jinghua Liu, et al.. (2025). Overcoming venetoclax resistance through heme-mediated NOXA/cyclin D1/Mcl-1 axis with a novel artemisinin conjugate. Blood Advances. 9(21). 5473–5488.

Ma, Shiyu, et al.. (2025). Case Report: Vanishing bile duct syndrome in Hodgkin’s lymphoma: a case highlighting jaundice and lymphadenopathy as early clues. Frontiers in Immunology. 16. 1561110–1561110.

Li, Ting, et al.. (2025). Pain mechanism and management strategy of rheumatoid arthritis. Frontiers in Pain Research. 6. 1693399–1693399.

Li, Wenze, et al.. (2025). Effectiveness and safety of teclistamab for relapsed or refractory multiple myeloma: a systematic review and meta-analysis. Frontiers in Immunology. 16. 1565407–1565407. 1 indexed citations

Yang, Wei, Sujun Gao, Xiaojing Yan, et al.. (2024). Latest results of a phase 2 study of IMM01 combined with azacitidine (AZA) as the first-line treatment in adults with higher risk myelodysplastic syndromes (MDS).. Journal of Clinical Oncology. 42(16_suppl). 6510–6510.

Zhang, Meng, Heyang Zhang, Rui Zhang, et al.. (2024). Monomorphic epitheliotropic intestinal T-cell lymphoma: report of four cases and literature review. Journal of International Medical Research. 52(8). 3649332684–3649332684. 1 indexed citations

Zhang, Ludan, et al.. (2024). A real-world experience of venetoclax combined with hypomethylating agents vs. monotherapy hypomethylating agents in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia patients. Frontiers in Pharmacology. 15. 1265840–1265840.

Jiang, Jiahui, et al.. (2024). Elucidating the therapeutic mechanism of Hengqing II decoction in Alzheimer's disease using network pharmacology and molecular docking techniques. Fitoterapia. 174. 105860–105860. 3 indexed citations

10.

Zhang, Jinjing, Ran Gao, Yuan Miao, et al.. (2023). Case Report: CD19 CAR T-cell therapy following autologous stem cell transplantation: a successful treatment for R/R CD20-negative transformed follicular lymphoma with TP53 mutation. Frontiers in Immunology. 14. 1307242–1307242. 2 indexed citations

11.

Tong, Hongyan, Sujun Gao, Wei Yang, et al.. (2023). Preliminary Results of a Phase 2 Study of IMM01 Combined with Azacitidine (AZA) As the First-Line Treatment in Adult Patients with Chronic Myelomonocytic Leukemia (CMML). Blood. 142(Supplement 1). 1859–1859. 4 indexed citations

12.

Yan, Haowen, et al.. (2023). DNA dynamic coding-based encryption algorithm for vector map considering global objects. Earth Science Informatics. 16(3). 2939–2954. 4 indexed citations

13.

Chen, Can, et al.. (2023). Porcine cardiac blood - Salvia miltiorrhiza root alleviates cerebral ischemia reperfusion injury by inhibiting oxidative stress induced apoptosis through PI3K/AKT/Bcl-2/Bax signaling pathway. Journal of Ethnopharmacology. 316. 116698–116698. 16 indexed citations

14.

Yan, Xiaojing, et al.. (2021). The Combined Measurement of Pelvic Organ Mobility and Hiatus Area Improves the Sensitivity of Transperineal Ultrasound When Detecting Pelvic Organ Prolapse. Frontiers in Medicine. 8. 727711–727711. 3 indexed citations

15.

Zhang, Jinjing, et al.. (2021). Pulmonary infiltration as the initial manifestation of chronic lymphoproliferative disorder of natural killer cells: a case report and literature review. BMC Pulmonary Medicine. 21(1). 94–94.

16.

Yan, Xiaojing, et al.. (2021). Transvaginal Real-Time Shear Wave Elastography in the Diagnosis of Endometrial Lesions. International Journal of General Medicine. Volume 14. 2849–2856. 10 indexed citations

17.

Zhang, Jinjing, et al.. (2018). Reactive plasmacytosis mimicking multiple myeloma associated with SFTS virus infection: a report of two cases and literature review. BMC Infectious Diseases. 18(1). 528–528. 14 indexed citations

18.

Xu, Jie, Wu Zhang, Xiaojing Yan, et al.. (2016). DNMT3A mutation leads to leukemic extramedullary infiltration mediated by TWIST1. Journal of Hematology & Oncology. 9(1). 106–106. 28 indexed citations

19.

Cao, Yudan, Xiaojing Yan, Zhang Li, & Anwei Ding. (2014). Study on detoxication of Euphorbia Pekinensis Radix processed with vinegar on rat small intestinal crypt epithelial cells IEC-6. China Journal of Chinese Materia Medica. 39(6). 1069–74. 2 indexed citations

20.

Gao, Ling, Xiaolong Wang, Shaoming Li, et al.. (2013). Decompression as a Treatment for Odontogenic Cystic Lesions of the Jaw. Journal of Oral and Maxillofacial Surgery. 72(2). 327–333. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact